Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 155 entries
Sorted by: Best Match Show Resources per page
Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells.

Stem cells international

Mathiasen AB, Hansen L, Friis T, Thomsen C, Bhakoo K, Kastrup J.
PMID: 23577035
Stem Cells Int. 2013;2013:353105. doi: 10.1155/2013/353105. Epub 2013 Mar 19.

Background. Regenerative therapy is an emerging treatment modality. To determine migration and retention of implanted cells, it is crucial to develop noninvasive tracking methods. The aim was to determine ex vivo magnetic resonance imaging (MRI) detection limits of ultrasmall...

Cite
Mathiasen AB, Hansen L, Friis T, et al. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int. 2013;2013:353105doi: 10.1155/2013/353105.
Mathiasen, A. B., Hansen, L., Friis, T., Thomsen, C., Bhakoo, K., & Kastrup, J. (2013). Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem cells international, 2013353105. https://doi.org/10.1155/2013/353105
Mathiasen, Anders Bruun, et al. "Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells." Stem cells international vol. 2013 (2013): 353105. doi: https://doi.org/10.1155/2013/353105
Mathiasen AB, Hansen L, Friis T, Thomsen C, Bhakoo K, Kastrup J. Optimal labeling dose, labeling time, and magnetic resonance imaging detection limits of ultrasmall superparamagnetic iron-oxide nanoparticle labeled mesenchymal stromal cells. Stem Cells Int. 2013;2013:353105. doi: 10.1155/2013/353105. Epub 2013 Mar 19. PMID: 23577035; PMCID: PMC3614076.
Copy Download .nbib Format: NLM
Rochelle salt - a structural reinvestigation with improved tools. I. The high-temperature para-electric phase at 308 K.

IUCrJ

Mo F, Mathiesen RH, Beukes JA, Vu KM.
PMID: 25610624
IUCrJ. 2015 Jan 01;2:19-28. doi: 10.1107/S2052252514022155. eCollection 2015 Jan 01.

The crystal structure of the high-temperature paraelectric phase of Rochelle salt (K(+)·Na(+)·C4H4O6 (2-)·4H2O) at 308 K has been reinvestigated using synchrotron X-ray diffraction with refinement parameters R(int) = 0.0123, final (shift/e.s.d.)max = 0.019, R 1(all) = 0.0371 and wR...

Cite
Mo F, Mathiesen RH, Beukes JA, et al. Rochelle salt - a structural reinvestigation with improved tools. I. The high-temperature para-electric phase at 308 K. IUCrJ. 2015;2:19-28doi: 10.1107/S2052252514022155.
Mo, F., Mathiesen, R. H., Beukes, J. A., & Vu, K. M. (2015). Rochelle salt - a structural reinvestigation with improved tools. I. The high-temperature para-electric phase at 308 K. IUCrJ, 219-28. https://doi.org/10.1107/S2052252514022155
Mo, Frode, et al. "Rochelle salt - a structural reinvestigation with improved tools. I. The high-temperature para-electric phase at 308 K." IUCrJ vol. 2 (2015): 19-28. doi: https://doi.org/10.1107/S2052252514022155
Mo F, Mathiesen RH, Beukes JA, Vu KM. Rochelle salt - a structural reinvestigation with improved tools. I. The high-temperature para-electric phase at 308 K. IUCrJ. 2015 Jan 01;2:19-28. doi: 10.1107/S2052252514022155. eCollection 2015 Jan 01. PMID: 25610624; PMCID: PMC4285877.
Copy Download .nbib Format: NLM
Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial.

Acta oncologica (Stockholm, Sweden)

Envold Bidstrup P, Mertz BG, Kroman N, Andersson M, Mathiesen UB, Vibe-Petersen J, Dalton SO, Johansen C.
PMID: 27219356
Acta Oncol. 2016 Sep - Oct;55(9):1239-1243. doi: 10.3109/0284186X.2016.1167957. Epub 2016 May 24.

No abstract available.

Cite
Envold Bidstrup P, Mertz BG, Kroman N, et al. Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial. Acta Oncol. 2016;55(9):1239-1243doi: 10.3109/0284186X.2016.1167957.
Envold Bidstrup, P., Mertz, B. G., Kroman, N., Andersson, M., Mathiesen, U. B., Vibe-Petersen, J., Dalton, S. O., & Johansen, C. (2016). Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial. Acta oncologica (Stockholm, Sweden), 55(9), 1239-1243. https://doi.org/10.3109/0284186X.2016.1167957
Envold Bidstrup, Pernille, et al. "Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial." Acta oncologica (Stockholm, Sweden) vol. 55,9 (2016): 1239-1243. doi: https://doi.org/10.3109/0284186X.2016.1167957
Envold Bidstrup P, Mertz BG, Kroman N, Andersson M, Mathiesen UB, Vibe-Petersen J, Dalton SO, Johansen C. Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial. Acta Oncol. 2016 Sep - Oct;55(9):1239-1243. doi: 10.3109/0284186X.2016.1167957. Epub 2016 May 24. PMID: 27219356.
Copy Download .nbib Format: NLM
Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study.

Stem cells international

Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A.
PMID: 29056973
Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19.

BACKGROUND: Ischemic heart failure (IHF) has a poor prognosis in spite of optimal therapy. We have established a new allogeneic Cardiology Stem Cell Centre adipose-derived stromal cell (CSCC_ASC) product from healthy donors. It is produced without animal products, in...

Cite
Kastrup J, Schou M, Gustafsson I, et al. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int. 2017;2017:8506370doi: 10.1155/2017/8506370.
Kastrup, J., Schou, M., Gustafsson, I., Nielsen, O. W., Møgelvang, R., Kofoed, K. F., Kragelund, C., Hove, J. D., Fabricius-Bjerre, A., Heitman, M., Haack-Sørensen, M., Lund, L. D., Johansen, E. M., Qayyum, A. A., Mathiasen, A. B., & Ekblond, A. (2017). Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem cells international, 20178506370. https://doi.org/10.1155/2017/8506370
Kastrup, Jens, et al. "Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study." Stem cells international vol. 2017 (2017): 8506370. doi: https://doi.org/10.1155/2017/8506370
Kastrup J, Schou M, Gustafsson I, Nielsen OW, Møgelvang R, Kofoed KF, Kragelund C, Hove JD, Fabricius-Bjerre A, Heitman M, Haack-Sørensen M, Lund LD, Johansen EM, Qayyum AA, Mathiasen AB, Ekblond A. Rationale and Design of the First Double-Blind, Placebo-Controlled Trial with Allogeneic Adipose Tissue-Derived Stromal Cell Therapy in Patients with Ischemic Heart Failure: A Phase II Danish Multicentre Study. Stem Cells Int. 2017;2017:8506370. doi: 10.1155/2017/8506370. Epub 2017 Sep 19. PMID: 29056973; PMCID: PMC5625749.
Copy Download .nbib Format: NLM
Physical estimation of triplet phases--effects of different radiation sources and modes for profile scans.

Journal of synchrotron radiation

Mo F, Hauback BC, Mathiesen RH, Kvick A, Weckert E.
PMID: 16687850
J Synchrotron Radiat. 1998 Nov 01;5:1369-74. doi: 10.1107/S0909049598006062.

A comparative study has been made of the intensity profiles from three-beam experiments to estimate triplet phases using radiation from a conventional sealed-tube X-ray source and two different synchrotron sources. Synchrotron radiation, with its much smaller angular divergence, narrower...

Cite
Mo F, Hauback BC, Mathiesen RH, et al. Physical estimation of triplet phases--effects of different radiation sources and modes for profile scans. J Synchrotron Radiat. 1998;5:1369-74doi: 10.1107/S0909049598006062.
Mo, F., Hauback, B. C., Mathiesen, R. H., Kvick, A., & Weckert, E. (1998). Physical estimation of triplet phases--effects of different radiation sources and modes for profile scans. Journal of synchrotron radiation, 51369-74. https://doi.org/10.1107/S0909049598006062
Mo, F, et al. "Physical estimation of triplet phases--effects of different radiation sources and modes for profile scans." Journal of synchrotron radiation vol. 5 (1998): 1369-74. doi: https://doi.org/10.1107/S0909049598006062
Mo F, Hauback BC, Mathiesen RH, Kvick A, Weckert E. Physical estimation of triplet phases--effects of different radiation sources and modes for profile scans. J Synchrotron Radiat. 1998 Nov 01;5:1369-74. doi: 10.1107/S0909049598006062. PMID: 16687850.
Copy Download .nbib Format: NLM
Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg.

International breastfeeding journal

Bystrova K, Widström AM, Matthiesen AS, Ransjö-Arvidson AB, Welles-Nyström B, Vorontsov I, Uvnäs-Moberg K.
PMID: 17488524
Int Breastfeed J. 2007 May 08;2:9. doi: 10.1186/1746-4358-2-9.

BACKGROUND: There are not many studies exploring parity differences in early lactation performance and the results obtained are fairly often contradictory. The present study investigated the effect of different maternity home practices in St. Petersburg, Russia, as well as...

Cite
Bystrova K, Widström AM, Matthiesen AS, et al. Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg. Int Breastfeed J. 2007;2:9doi: 10.1186/1746-4358-2-9.
Bystrova, K., Widström, A. M., Matthiesen, A. S., Ransjö-Arvidson, A. B., Welles-Nyström, B., Vorontsov, I., & Uvnäs-Moberg, K. (2007). Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg. International breastfeeding journal, 29. https://doi.org/10.1186/1746-4358-2-9
Bystrova, Ksenia, et al. "Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg." International breastfeeding journal vol. 2 (2007): 9. doi: https://doi.org/10.1186/1746-4358-2-9
Bystrova K, Widström AM, Matthiesen AS, Ransjö-Arvidson AB, Welles-Nyström B, Vorontsov I, Uvnäs-Moberg K. Early lactation performance in primiparous and multiparous women in relation to different maternity home practices. A randomised trial in St. Petersburg. Int Breastfeed J. 2007 May 08;2:9. doi: 10.1186/1746-4358-2-9. PMID: 17488524; PMCID: PMC1878468.
Copy Download .nbib Format: NLM
Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP).

Endocrine

Kissmeyer A, Mathiasen IS, Latini S, Binderup L.
PMID: 21153172
Endocrine. 1995 Apr;3(4):263-6. doi: 10.1007/BF03021403.

Vitamin D(3), 25-hydroxyvitamin D(3) (25OHD(3)) and 1α,25-dihydroxyvitamin D(3) (1α,25(OH)(2)D(3)) bind to the vitamin D binding protein (DBP) in the serum. During the development of synthetic vitamin D analogues, it has been shown that the majority of analogues bind to...

Cite
Kissmeyer A, Mathiasen IS, Latini S, et al. Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine. 1995;3(4):263-6doi: 10.1007/BF03021403.
Kissmeyer, A., Mathiasen, I. S., Latini, S., & Binderup, L. (1995). Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine, 3(4), 263-6. https://doi.org/10.1007/BF03021403
Kissmeyer, A, et al. "Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP)." Endocrine vol. 3,4 (1995): 263-6. doi: https://doi.org/10.1007/BF03021403
Kissmeyer A, Mathiasen IS, Latini S, Binderup L. Pharmacokinetic studies of vitamin D analogues: relationship to vitamin D binding protein (DBP). Endocrine. 1995 Apr;3(4):263-6. doi: 10.1007/BF03021403. PMID: 21153172.
Copy Download .nbib Format: NLM
Survival and failure types after radiation therapy of vulvar cancer.

Clinical and translational radiation oncology

Vorbeck CS, Vogelius IR, Banner-Voigt MLVC, Mathiesen HF, Mirza MR.
PMID: 29594213
Clin Transl Radiat Oncol. 2017 Jul 07;5:20-27. doi: 10.1016/j.ctro.2017.06.002. eCollection 2017 Aug.

BACKGROUND AND PURPOSE: Describe the survival rates and distribution of events on competing failure types in vulvar carcinoma after treatment with chemoradiation (CRT) or radiation (RT) alone.MATERIAL AND METHODS: We included patients with vulvar carcinoma treated with CRT or...

Cite
Vorbeck CS, Vogelius IR, Banner-Voigt MLVC, et al. Survival and failure types after radiation therapy of vulvar cancer. Clin Transl Radiat Oncol. 2017;5:20-27doi: 10.1016/j.ctro.2017.06.002.
Vorbeck, C. S., Vogelius, I. R., Banner-Voigt, M. L. V. C., Mathiesen, H. F., & Mirza, M. R. (2017). Survival and failure types after radiation therapy of vulvar cancer. Clinical and translational radiation oncology, 520-27. https://doi.org/10.1016/j.ctro.2017.06.002
Vorbeck, Christina Steen, et al. "Survival and failure types after radiation therapy of vulvar cancer." Clinical and translational radiation oncology vol. 5 (2017): 20-27. doi: https://doi.org/10.1016/j.ctro.2017.06.002
Vorbeck CS, Vogelius IR, Banner-Voigt MLVC, Mathiesen HF, Mirza MR. Survival and failure types after radiation therapy of vulvar cancer. Clin Transl Radiat Oncol. 2017 Jul 07;5:20-27. doi: 10.1016/j.ctro.2017.06.002. eCollection 2017 Aug. PMID: 29594213; PMCID: PMC5833899.
Copy Download .nbib Format: NLM
Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors.

Dementia and geriatric cognitive disorders extra

Rogne S, Vangberg T, Eldevik P, Wikran G, Mathiesen EB, Schirmer H.
PMID: 28101099
Dement Geriatr Cogn Dis Extra. 2016 Nov 25;6(3):529-540. doi: 10.1159/000450885. eCollection 2016.

BACKGROUND/AIMS: Subjective memory complaints (SMC) are strong predictors of mild cognitive impairment (MCI) and subsequent Alzheimer's disease. Our aims were to see if fully automated cerebral MR volume measurements could distinguish subjects with SMC and MCI from controls, and...

Cite
Rogne S, Vangberg T, Eldevik P, et al. Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors. Dement Geriatr Cogn Dis Extra. 2016;6(3):529-540doi: 10.1159/000450885.
Rogne, S., Vangberg, T., Eldevik, P., Wikran, G., Mathiesen, E. B., & Schirmer, H. (2016). Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors. Dementia and geriatric cognitive disorders extra, 6(3), 529-540. https://doi.org/10.1159/000450885
Rogne, Sigbjørn, et al. "Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors." Dementia and geriatric cognitive disorders extra vol. 6,3 (2016): 529-540. doi: https://doi.org/10.1159/000450885
Rogne S, Vangberg T, Eldevik P, Wikran G, Mathiesen EB, Schirmer H. Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors. Dement Geriatr Cogn Dis Extra. 2016 Nov 25;6(3):529-540. doi: 10.1159/000450885. eCollection 2016. PMID: 28101099; PMCID: PMC5216191.
Copy Download .nbib Format: NLM
Norwegian unions fight for the right to full-time positions.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

Mathiesen ME.
PMID: 27661818
Nurs Stand. 1994 Jan 05;8(15):12. doi: 10.7748/ns.8.15.12.s25.

Norway Too many of the country's nurses work part-time, according to the Norwegian Nurses Association (NNA).

Cite
Mathiesen ME. Norwegian unions fight for the right to full-time positions. Nurs Stand. 1994;8(15):12doi: 10.7748/ns.8.15.12.s25.
Mathiesen, M. E. (1994). Norwegian unions fight for the right to full-time positions. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 8(15), 12. https://doi.org/10.7748/ns.8.15.12.s25
Mathiesen, Morten E. "Norwegian unions fight for the right to full-time positions." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 8,15 (1994): 12. doi: https://doi.org/10.7748/ns.8.15.12.s25
Mathiesen ME. Norwegian unions fight for the right to full-time positions. Nurs Stand. 1994 Jan 05;8(15):12. doi: 10.7748/ns.8.15.12.s25. PMID: 27661818.
Copy Download .nbib Format: NLM
Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study.

Endocrine connections

Mathiesen JS, Kroustrup JP, Vestergaard P, Poulsen PL, Rasmussen ÅK, Feldt-Rasmussen U, Schytte S, Londero SC, Pedersen HB, Hahn CH, Bentzen J, Möller S, Gaustadnes M, Rossing M, Nielsen FC, Brixen K, Godballe C.
PMID: 30550378
Endocr Connect. 2019 Jan 01;8(1):1-7. doi: 10.1530/EC-18-0494.

A recent study proposed new TNM groupings for better survival discrimination among stage groups for medullary thyroid carcinoma (MTC) and validated these groupings in a population-based cohort in the United States. However, it is unknown how well the groupings...

Cite
Mathiesen JS, Kroustrup JP, Vestergaard P, et al. Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr Connect. 2019;8(1):1-7doi: 10.1530/EC-18-0494.
Mathiesen, J. S., Kroustrup, J. P., Vestergaard, P., Poulsen, P. L., Rasmussen, �. �. K., Feldt-Rasmussen, U., Schytte, S., Londero, S. C., Pedersen, H. B., Hahn, C. H., Bentzen, J., Möller, S., Gaustadnes, M., Rossing, M., Nielsen, F. C., Brixen, K., & Godballe, C. (2019). Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocrine connections, 8(1), 1-7. https://doi.org/10.1530/EC-18-0494
Mathiesen, Jes Sloth, et al. "Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study." Endocrine connections vol. 8,1 (2019): 1-7. doi: https://doi.org/10.1530/EC-18-0494
Mathiesen JS, Kroustrup JP, Vestergaard P, Poulsen PL, Rasmussen ÅK, Feldt-Rasmussen U, Schytte S, Londero SC, Pedersen HB, Hahn CH, Bentzen J, Möller S, Gaustadnes M, Rossing M, Nielsen FC, Brixen K, Godballe C. Replication of newly proposed TNM staging system for medullary thyroid carcinoma: a nationwide study. Endocr Connect. 2019 Jan 01;8(1):1-7. doi: 10.1530/EC-18-0494. PMID: 30550378; PMCID: PMC6330714.
Copy Download .nbib Format: NLM
Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016.

Neurology. Clinical practice

Johnsen B, Strand BH, Martinaityte I, Mathiesen EB, Schirmer H.
PMID: 34992969
Neurol Clin Pract. 2021 Dec;11(6):e856-e866. doi: 10.1212/CPJ.0000000000001115.

BACKGROUND AND OBJECTIVES: Physical capacity and cardiovascular risk profiles seem to be improving in the population. Cognition has been improving due to a birth cohort effect, but evidence is conflicting on whether this improvement remains in the latest decades...

Cite
Johnsen B, Strand BH, Martinaityte I, et al. Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016. Neurol Clin Pract. 2021;11(6):e856-e866doi: 10.1212/CPJ.0000000000001115.
Johnsen, B., Strand, B. H., Martinaityte, I., Mathiesen, E. B., & Schirmer, H. (2021). Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016. Neurology. Clinical practice, 11(6), e856-e866. https://doi.org/10.1212/CPJ.0000000000001115
Johnsen, Bente, et al. "Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016." Neurology. Clinical practice vol. 11,6 (2021): e856-e866. doi: https://doi.org/10.1212/CPJ.0000000000001115
Johnsen B, Strand BH, Martinaityte I, Mathiesen EB, Schirmer H. Improved Cognitive Function in the Tromsø Study in Norway From 2001 to 2016. Neurol Clin Pract. 2021 Dec;11(6):e856-e866. doi: 10.1212/CPJ.0000000000001115. PMID: 34992969; PMCID: PMC8723922.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 155 entries